Title
Use of Generic Names in DOH Prescriptions
Law
Doh Administrative Order No. 169, S. 2004
Decision Date
Sep 6, 2004
DOH Administrative Order No. 169 mandates the exclusive use of generic names for all drug prescriptions and orders in Department of Health facilities, promoting the Generics Act of 1988 to enhance accessibility and compliance in pharmaceutical practices.

Law Summary

Objectives of the Order

  • Establish guidelines to enforce exclusive generic name use in all Department of Health (DOH) facilities.
  • Promote institutionalization of generic drug use by identifying key personnel and their responsibilities within DOH.
  • Implement a monitoring system to ensure compliance with generic prescription requirements.

Scope and Applicability

  • Applicable to all DOH-controlled facilities including hospitals, centers for health development, bureaus, offices, medical centers, sanitaria, and other operational units.

General Guidelines for Compliance

  • Sole use of generic names in all drug-related transactions including procurement, prescription, dispensing, and administration.
  • Inclusion of patent-protected drugs under generic name use without brand name specification.
  • Heads of DOH facilities designated as National Drug Policy Compliance Officers responsible for promulgation, dissemination, and enforcement of the order.
  • Non-compliance reports to be elevated with sanctions applied under RA 6675 and related laws.

Organizational Structure for Implementation

  • Therapeutics Committees or designated personnel to serve as National Drug Policy Compliance Officers providing oversight and reporting to the facility head.
  • Establishment of "Gamot Mabisa Abot-Kaya (GMA-50) Help Desk" in each DOH facility for public access to low-cost essential drugs, information on drug availability, rational drug use, and handling public complaints.
  • Nurses’ stations to maintain updated lists of available drugs; physicians and nurses to prescribe based on hospital stock’s generic equivalents.
  • Inclusion of generics promotion activities such as training, information dissemination, GMA-50 Help Desk operation, and annual Generics Month celebrations in facility work plans.

Monitoring and Reporting Requirements

  • Quarterly submission by facility heads detailing activities related to the Generics Law, including listing personnel violating generic prescription rules.

Legal Provisions

  • Separability clause ensuring other provisions remain effective if any part is invalidated.
  • Repealing clause modifying or repealing conflicting previous orders or issuances.
  • Immediate effectivity upon publication in two newspapers of general circulation.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster—building context before diving into full texts.